Managed Care Review BoardTM - An Analysis of Current and Emerging Therapies and Benefit Design Considerations for Psoriasis and Psoriatic Arthritis Live Webcast
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
| DAY | DATE | TIME |
| Thursday | September 8 | 4:00-6:00 PM ET |
| Thursday | September 15 | 4:00-6:00 PM ET |
| Monday | September 26 | 4:00-6:00 PM ET |
| Tuesday | September 27 | 4:00-6:00 PM ET |
|
Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care University of Utah Health Sciences Center |
|
Joseph E. Biskupiak, PhD, MBA Research Professor & Director, PORC University of Utah |
|
James Kenney, RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care |
|
Kenneth Schaecher, MD, FACP, CPC Medical Director Select Health |
|
Paul Yamauchi, MD, PhD Clinical Assistant Professor of Dermatology David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Institute Dermatology Institute & Skin Care Center, Inc. Clinical Science Institute |
|
Brian Kaye, MD, FACP Rheumatologist Sutter East Bay Medical Foundation Clinical Professor of Medicine University of California at San Francisco Adjunct Professor College of Education and Health Sciences Touro University |
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for psoriatic disease including: physicians, pharmacists, registered nurses, and case managers
Psoriasis is one of the most common autoimmune diseases to develop in genetically susceptible individuals with an estimated 7.5 million Americans afflicted by psoriasis; and psoriatic arthritis is considered to be one of the most disabling types of arthritis affecting as many as 2.3 million Americans. Direct annual health care costs assigned to the management of psoriatic disease is estimated to be as high as $2.0-3.0 billion. As novel agents become available, treatment decision making is becoming more complex and managed care professionals need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes.
The Managed Care Review BoardTM format features multi-specialty, multi-professional managed care, and clinical specialist faculty who collaborate on the review of the clinical data, current guidelines, and economic data of a specific class of therapeutics. It uniquely provides the audience with a review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialist faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients' psoriatic disease. This approach supports managed care pharmacists by enhancing the results of their own health care organization's systematic literature reviews and analyses.
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Analyze the available evidence-base for the treatment of psoriasis and psoriatic arthritis (PsA) in a true CER framework
- Assess current and emerging therapies for the treatment of psoriasis and PsA and cite their clinical trial data
- Address nonadherence factors associated with various therapies for psoriasis and PsA
- Integrate interventions to coordinate health plan and affiliated providers efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and PsA
- Provide accurate and appropriate counsel as part of the managed care treatment team
- Provide appropriate care and counsel for patients and their families
|
Introduction & Overview |
|
Evolving Treatment Options and Clinical Benefits Update in Psoriasis and
Psoriatic Arthritis
Brian Kaye, MD, FACP Paul Yamauchi, MD, PhD |
|
Current Practice Guidelines Review and Application of CER Analyses to
Improve Treatment Decisions
Kenneth Schaecher, MD, FACP, CPC |
|
Faculty Idea Exchange Faculty Panel |
|
Analyzing the Available Data to Assess the Value of Psoriasis and Psoriatic Arthritis Treatment Options September 8 and 26: Diana Brixner, RPh, PhD, FAMCP September 15 and 27: Joseph E. Biskupiak, PhD, MBA |
|
Plan Benefit Designs and Specialty Pharmacy Considerations in a New Era of Health Care Reform James Kenney, RPh, MBA |
| Faculty Idea Exchange, Q&A Session, Closing Commentary |
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
 |
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
This program has been assigned ACPE University Activity #0797-9999-16-030-L04-P. This program is designated for up to 2.0 contact hours (0.20 CEUs) of continuing pharmacy education credit.
Type of Activity: Application
For Pharmacists: Upon receipt of a completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Nursing Continuing Education
Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation
2.0 contact hours may be earned for successful completion of this activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Fee Information
There is no fee for this educational activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.